MBX Biosciences, Inc. MBX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s software and technology licenses, net?
- MBX Biosciences, Inc. (MBX) reported software and technology licenses, net of $579K in Q1 2026.
- How has MBX Biosciences, Inc.'s software and technology licenses, net changed year-over-year?
- MBX Biosciences, Inc.'s software and technology licenses, net increased by 1058.0% year-over-year, from $50K to $579K.
- What is the long-term trend for MBX Biosciences, Inc.'s software and technology licenses, net?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s software and technology licenses, net has grown at a 176.8% compound annual growth rate (CAGR), from $50K to $383K.